SG/CALL/AMGEN/380/0.1/20.09.24 Share Price

DE000SU6VRW4

Market Closed - Boerse Frankfurt Warrants 20:49:23 31/05/2024 BST
0.14 ^EUR	+7.69%

3 months

+16.67%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart AMGEN INC.

Latest news about AMGEN INC.

Amgen : 2024 Annual Meeting of Stockholders Presentation	05-31	PU
US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment	05-28	RE
Amgen's Rare-Disease Treatment Biosimilar Bkemv Gets FDA Approval	05-28	DJ
Weight-loss drug forecasts jump to $150 billion as supply grows	05-28	RE

More news

Quotes 5-day view

Date	Price	Change
31/05/24	0.14	+7.69%
30/05/24	0.13	+30.00%
29/05/24	0.1	-16.67%
28/05/24	0.12	-7.69%
27/05/24	0.13	-7.14%

Real-time Boerse Frankfurt Warrants

Last update May 31, 2024 at 08:49 pm

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	AMGEN INC.
Issuer	Société Générale
WKN	SU6VRW
ISIN	DE000SU6VRW4
Date issued	10/01/2024
Strike	380 $
Maturity	20/09/2024 (110 Days)
Parity	10 : 1
Emission price	0.57 €
Emission volume	N/A
Settlement	Barausgleich
Currency	EUR

Technical Indicators

Highest since issue	0.82 €
Lowest since issue	0.07 €
Spread	0.01 €
Spread %	7.14%

Company Profile

Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other (5.8%): primarily royalties. The United States account for 70.3% of net sales.

Sector

More about the company